TITLE

Europe dithers over stem cell patents

AUTHOR(S)
Mitchell, Peter
PUB. DATE
February 2003
SOURCE
Nature Medicine;Feb2003, Vol. 9 Issue 2, p154
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Reports plans of the European Commission to restrict the scope of stem cell technology patents. Development of stem cell-based therapeutics; Assessment of the patentability of biotechnology-based inventions; Ethics of stem cell research.
ACCESSION #
9028809

 

Related Articles

  • Patents for Human Embryonic Stem Cells? Carlin, Robert // Medical Device Technology;Jun2003, Vol. 14 Issue 5, p16 

    Focuses on the patentability of human embryonic stem cells in Great Britain. Definition of stem cells; Processes for obtaining stem cells; Potential of totipotent cell; Commercial exploitation of inventions concerning human embryonic pluripotent stem cells.

  • Recent patents in stem cell research.  // Nature Biotechnology;Apr99, Vol. 17 Issue 4, p396 

    Presents information on patents on stem cell research. Subject of the research; Name of assignee; Status.

  • Patent Watch.  // Nature Reviews Drug Discovery;Oct2003, Vol. 2 Issue 10, p766 

    Reports on rules for stem cell patents in Great Britain. Patentability of inventions involving human embryonic cells.

  • US company comes under fire over patent on umbilical cord cells. Butler, Declan // Nature;7/11/1996, Vol. 382 Issue 6587, p99 

    Reports that research groups are planning to challenge a European patent on the use stored stem cells from umbilical cord blood granted to the Biocyte Corp. Moral issue of patenting a human tissue.

  • Say no to stem cell patents. Coghlan, Andy // New Scientist;5/18/2002, Vol. 174 Issue 2343, p5 

    Reports the stand of the European Group on Ethics in Science and New Technologies regarding the patenting of undifferentiated stem cells. Favor on the creation of an European-wide bank of unmodififed stem cells; Influence on the type of stem cell patent applications granted by the European...

  • Patent watch.  // Nature Reviews Drug Discovery;Oct2002, Vol. 1 Issue 10, p750 

    Reports on developments concerning patents in Europe and the United States as of October 2002. Oral proceedings of the Opposition Division of the European Patent Office concerning the use of genetic engineering to isolate stem cells from more differentiated cells to obtain pure stem-cell...

  • Opponents of stem-cell patent win restrictions. Abbott, Alison; Schmidt, Oliver // Nature;8/1/2002, Vol. 418 Issue 6897, p470 

    Reports on the restriction in the scope of patent covering technologies for purifying human and animal embryonic stem cells by the European Patent Office in 2002. Details of the patent coverage; Groups that filed objections to the patent; Claim against the methods involved in the patent; Basis...

  • Patent truce.  // New Scientist;2/5/2011, Vol. 209 Issue 2798, p4 

    The article focuses on an international pact to prevent lengthy patent disputes concerning induced pluripotent stem cells, with patents owned by Kyoto University in Japan and biopharmaceutical company iPierian being pooled to avoid disputes that would hinder the creation of medical treatments...

  • International Stem Cell Gets Parthenogenetic Patent. Chambers, Heather // San Diego Business Journal;6/14/2010, Vol. 31 Issue 24, p6 

    The article reports on the potential of the International Stem Cell Corp. in Oceanside, California, to receive a patent related to the development of human parthenogenetic stem cells.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics